KUBOTA PHARMACEUTICAL HOLDINGS CO LTD - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 10, 2016

Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231xexhibit312.htm
EX-3.01 - EXHIBIT 3.01 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit301.htm
EX-3.02 - EXHIBIT 3.02 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit302.htm
EX-10.25 - EXHIBIT 10.25 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit1025.htm
EX-21.1 - EXHIBIT 21.1 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit211.htm
EX-31.1 - EXHIBIT 31.1 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231xexhibit311.htm
EX-10.26 - EXHIBIT 10.26 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit1026.htm
EX-32.1 - EXHIBIT 32.1 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231xexhibit321.htm
EX-32.2 - EXHIBIT 32.2 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231xexhibit322.htm
EX-10.16 - EXHIBIT 10.16 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231exhibit1016.htm
10-K - 10-K - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela2015q410k.htm
EX-10.17 - EXHIBIT 10.17 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit1017.htm


Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-193811) of Acucela, Inc. of our reports dated March 10, 2016, with respect to the financial statements and the effectiveness of internal control over financial reporting of Acucela Inc. included in this Annual Report (Form 10-K) of Acucela, Inc. for the year ended December 31, 2015.

/s/ Ernst & Young LLP
Seattle, Washington
March 10, 2016


KUBOTA PHARMACEUTICAL HOLDINGS CO LTD Reports